Estudios originales
Published on 5 de mayo de 2025 | http://doi.org/10.5867/medwave.2025.04.3045
Influence of different treatment modalities on the sexual function of breast cancer survivors: An observational ambispective study
Back to article
FSFI scores of patients on treatment with gonadotropin-releasing hormone agonists versus those who do not receive it (n = 149).
| Desire | 3.6 (3.6 - 3.6) | 3.6 (3.6 - 4.2) | < 0 to > 0 |
| Arousal | 4.2 (3.9 - 4.5) | 4.2 (3.6 -4.5) | -0.3 to 0.3 |
| Lubrication | 4.2 (4.2 - 4.5) | 4.2 (3.9 - 4.8) | -0.3 to 0.3 |
| Orgasm | 5.2 (5.0 - 5.6) | 4.4 (4.0 - 5.2) | 0.4 to 1.2 |
| Satisfaction | 5.2 (5.0 - 5.2) | 5.2 (4.0 - 5.2) | < 0 to 0.4 |
| Pain | 4.8 (4.8 - 5.2) | 4.0 (3.6 - 4.8) | 0.4 to 1.2 |
FSFI, Female Sexual Function Index. CI, confidence interval.
Notes: 1Median (quartile 1 - quartile 3). 2Confidence interval of the difference in the median.
Source: Prepared by the authors based on the study results.